Christopher J. Reading is the CEO of US Physical Therapy, Inc. since 2004, with a background as a licensed physical therapist. Under his leadership, the company has grown and expanded its footprint in the healthcare industry. Reading has consistently aligned...

Christopher J. Reading is the CEO of US Physical Therapy, Inc. since 2004, with a background as a licensed physical therapist. Under his leadership, the company has grown and expanded its footprint in the healthcare industry. Reading has consistently aligned company performance with executive compensation, using metrics like Adjusted EBITDA to drive results. With a total compensation of over $3.7 million in 2023, his pay includes salary, bonuses, and vested stocks, highlighting how much he has at stake in the company’s success. Reading has also actively participated in issuing stocks, showing confidence in the growth of US Physical Therapy. An interesting note is that, in the previous years, his compensation had notable fluctuations; for instance, it peaked at over $4.1 million in 2021, showcasing his drive for performance and results. He emphasizes retaining talent and aligning interests with shareholders. As a leader dedicated to healthcare improvement, Reading's experience as a physical therapist adds a unique perspective to his role at the helm of US Physical Therapy.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

U

Christopher J. Reading

CEO of US Physical Therapy

Education

MBA from University of Houston

Field of Expertise

Business & Management

Sector of Economy

Healthcare

Born

January 1, 1964 - 61 years ago

CEO of US Physical Therapy for

21 years 5 months (Jan 2004 - Present)

Previous Experience

Joined US Physical Therapy in 2004

Rivals

Competitors/colleagues of Christopher J. Reading

Holdings

See how much did Christopher J. Reading make over time.

Christopher Reading's stock holdings in US Physical Therapy reveal his strong commitment to the company. In recent years, he has held substantial restricted stock, which demonstrates his belief in the company's future. As of 2023, he had 14,200 shares vested...

Christopher Reading's stock holdings in US Physical Therapy reveal his strong commitment to the company. In recent years, he has held substantial restricted stock, which demonstrates his belief in the company's future. As of 2023, he had 14,200 shares vested from previous grants, valued at about $1.32 million, showing a significant portion of his wealth tied to the company's performance. Notably, he saw substantial holdings in 2021 at the peak of $4.1 million in total compensation, indicating times when his wealth was closely linked to US Physical Therapy's success. His stock actions suggest he is confident in the company's growth trajectory, and this vested interest is crucial for aligning leadership with investor interests.

Mar 17, 2025

U

shares

USPH @ $76.50

Total Stock Sold

$20.65M

USPH

$20.65M

360,953 USPH shares

What if they kept their stock?

If Christopher J. Reading didn't sell their stock, today they would have:
Extra USPH360,953 shares worth $28.56M.
This is 38.29% and $7.91M more than what they got when they sold the stock.

Insider Trading

See recent insider trades of Christopher J. Reading.

USPH

20,250 shares

USPH

Feb 24, 2025

Received

USPH

$290.75K

USPH at $100.26/share

May 30, 2024

Sale

USPH

$212.37K

USPH at $101.13/share

May 28, 2024

Sale

USPH

16,200 shares

USPH

Feb 26, 2024

Received

USPH

10,000 shares

USPH

Feb 20, 2023

Received

USPH

$450.00K

USPH at $90.00/share

Dec 5, 2022

Sale

USPH

$900.10K

USPH at $90.01/share

Dec 2, 2022

Sale

USPH

20,000 shares

USPH

Mar 11, 2022

Received

USPH

$1.13M

USPH at $93.89/share

Dec 17, 2021

Sale

USPH

11,200 shares

USPH

Feb 22, 2021

Received

Compensation History

See how much did Christopher J. Reading make over time.

In 2023, Christopher J. Reading's total compensation reached over $3.7 million, anchored by a base salary of $960,000 and a cash bonus of $777,600 from the executive incentive plan. Additionally, he received significant stock awards, which contribute to his long-term wealth and reflect his performance-driven approach to pay. This compensation strategy is designed to motivate and retain top executives while aligning their interests with those of shareholders. Just a couple of years ago, in 2021, Reading's total compensation peaked at over $4.1 million, demonstrating the impact of strong performance metrics on executive pay. His pay packages have evolved, fluctuating with company performance, showing a clear connection between his compensation and the health of US Physical Therapy.

Year

2023

Total Compensation

$3.06M

Salary

$960.00K

Board Justification

The compensation program is designed to attract and retain talented executives, align their interests with those of stockholders, and reward performance that drives long-term growth.

Bonus

$777.60K

Board Justification

Cash bonus earned under the 2023 Executive Incentive Plan, paid on March 6, 2024.

Other

$3.56K

Board Justification

Represents the value of life insurance premiums for life insurance coverage provided to the Named Executive Officers.

Restricted Stock

$1.32M(14.2K restricted common stock)

Board Justification

Awarded 6,200 shares under the Objective Long-Term Incentive Plan and 10,000 shares under the Discretionary Long-Term Incentive Plan, both of which vested in 2023.

Performance Metrics

The primary performance metric for determining compensation was Adjusted EBITDA, with specific targets set for the 2023 fiscal year.